Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Kratom Regulation topic
No spam. Unsubscribe anytime.
Committee sends kratom consumer‑protection bill for amendment work after hours of mixed testimony
Summary
Senate Bill 14-18 would create a regulatory framework for kratom — banning adulterated or high‑potency synthetics, requiring testing, labeling and a 21+ age limit — and was sent to the 14th order for possible amendments after testimony from scientists, clinicians, retailers, grieving families and law‑enforcement officials.
Senate Bill 14-18, sponsored by Senator Tammy Nichols, would create Idaho’s first enforceable public‑safety framework for kratom products: limit 7‑hydroxymitragynine to low natural levels, ban synthetic/adulterated products, require third‑party testing and labeling, and restrict retail sales to buyers 21 and older. Senator Nichols said the goal is to 'target the high‑risk products' while preserving access to natural leaf kratom.
Testimony over several hours split sharply. Supporters — including distributors, retailers and some addiction specialists — said adulteration and synthetic 7‑OH production are driving harms and that regulation (testing, labeling, age limits and penalties for bad actors) is preferable to a full ban. The sponsor said testing and compliance costs fall to processors and manufacturers, not the state, and described a three‑strike enforcement scheme with civil penalties and potential injunctions.
Opponents — including coroner and some public‑safety witnesses — pointed to local kratom‑involved fatalities and urged stricter controls or an outright ban. Steve Rustici and other family members recounted the March 2025 death of their daughter and urged stronger action. Coroner Shanti Sanchez testified she has investigated multiple kratom‑involved deaths in Bonneville County and urged caution about reliance on industry self‑certification.
After hearing more than a dozen witnesses on both sides, the committee voted to send SB 14-18 to the Senate's 14th order for possible amendments; the sponsor signaled she would accept additional labeling and clarifying language and clarified that manufacturers/processors would bear testing costs.
